Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 192


STAAR: a randomised controlled trial of electronic adherence monitoring with reminder alarms and feedback to improve clinical outcomes for children with asthma.

Morton RW, Elphick HE, Rigby AS, Daw WJ, King DA, Smith LJ, Everard ML.

Thorax. 2017 Apr;72(4):347-354. doi: 10.1136/thoraxjnl-2015-208171. Epub 2016 Nov 4.


Serious Asthma Events with Budesonide plus Formoterol vs. Budesonide Alone.

Peters SP, Bleecker ER, Canonica GW, Park YB, Ramirez R, Hollis S, Fjallbrant H, Jorup C, Martin UJ.

N Engl J Med. 2016 Sep 1;375(9):850-60. doi: 10.1056/NEJMoa1511190.


Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma.

Stempel DA, Szefler SJ, Pedersen S, Zeiger RS, Yeakey AM, Lee LA, Liu AH, Mitchell H, Kral KM, Raphiou IH, Prillaman BA, Buaron KS, Yun Kirby S, Pascoe SJ; VESTRI Investigators.

N Engl J Med. 2016 Sep 1;375(9):840-9. doi: 10.1056/NEJMoa1606356.


Cost-Utility Analysis of Long-Acting Beta Agonists versus Leukotriene Receptor Antagonists in Older Adults with Persistent Asthma Receiving Concomitant Inhaled Corticosteroid Therapy.

Altawalbeh SM, Thorpe JM, Thorpe CT, Smith KJ.

Value Health. 2016 Jul-Aug;19(5):537-43. doi: 10.1016/j.jval.2016.02.004. Epub 2016 Apr 6.


Asthma prescribing, ethnicity and risk of hospital admission: an analysis of 35,864 linked primary and secondary care records in East London.

Hull SA, McKibben S, Homer K, Taylor SJ, Pike K, Griffiths C.

NPJ Prim Care Respir Med. 2016 Aug 18;26:16049. doi: 10.1038/npjpcrm.2016.49.


Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.

Virchow JC, Backer V, Kuna P, Prieto L, Nolte H, Villesen HH, Ljørring C, Riis B, de Blay F.

JAMA. 2016 Apr 26;315(16):1715-25. doi: 10.1001/jama.2016.3964.


Budesonide + formoterol fumarate dihydrate for the treatment of asthma.

Wolthers OD.

Expert Opin Pharmacother. 2016;17(7):1023-30. doi: 10.1517/14656566.2016.1165207. Epub 2016 Apr 12. Review.


Severe or life-threatening asthma exacerbation: patient heterogeneity identified by cluster analysis.

Sekiya K, Nakatani E, Fukutomi Y, Kaneda H, Iikura M, Yoshida M, Takahashi K, Tomii K, Nishikawa M, Kaneko N, Sugino Y, Shinkai M, Ueda T, Tanikawa Y, Shirai T, Hirabayashi M, Aoki T, Kato T, Iizuka K, Homma S, Taniguchi M, Tanaka H.

Clin Exp Allergy. 2016 Aug;46(8):1043-55. doi: 10.1111/cea.12738. Epub 2016 May 24.


[Ten years comparison of diagnosis and treatment of asthma in urban children in China].

Sha L, Liu C, Shao M, Chen Y.

Zhonghua Er Ke Za Zhi. 2016 Mar;54(3):182-6. doi: 10.3760/cma.j.issn.0578-1310.2016.03.005. Chinese.


Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone.

Stempel DA, Raphiou IH, Kral KM, Yeakey AM, Emmett AH, Prazma CM, Buaron KS, Pascoe SJ; AUSTRI Investigators.

N Engl J Med. 2016 May 12;374(19):1822-30. doi: 10.1056/NEJMoa1511049. Epub 2016 Mar 6.


Knowledge and perceptions of asthma in Zambia: a cross-sectional survey.

Jumbe Marsden E, Somwe SW, Chabala C, Soriano JB, Vallès CP, Anchochea J.

BMC Pulm Med. 2016 Feb 12;16:33. doi: 10.1186/s12890-016-0195-3. Erratum in: BMC Pulm Med. 2016;16:44.


Pre-hospital use of inhaled corticosteroids and inhaled beta agonists and incidence of ARDS: A population-based study.

Mangi AM, Bansal V, Li G, Pieper MS, Gajic O, Festic E.

Acta Med Acad. 2015;44(2):109-16. doi: 10.5644/ama2006-124.138.


Healthcare utilisation by pregnant patients with asthma in South Korea: a cohort study using nationwide claims data.

Lee CH, Kim J, Jang EJ, Kim YJ, Choi S, Lee JH, Kim DK, Yim JJ, Yoon HI.

BMJ Open. 2015 Nov 6;5(11):e008416. doi: 10.1136/bmjopen-2015-008416.


Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments.

Trudo F, Kern DM, Davis JR, Tunceli O, Zhou S, Graham EL, Strange C, Williams SA.

Int J Chron Obstruct Pulmon Dis. 2015 Sep 28;10:2055-66. doi: 10.2147/COPD.S90658. eCollection 2015.


Efficacy of a new intravenous β2-adrenergic agonist (bedoradrine, MN-221) for patients with an acute exacerbation of asthma.

House SL, Matsuda K, O'Brien G, Makhay M, Iwaki Y, Ferguson I, Lovato LM, Lewis LM.

Respir Med. 2015 Oct;109(10):1268-73. doi: 10.1016/j.rmed.2015.08.003. Epub 2015 Aug 14.


Analysis of prescription pattern and guideline adherence in the management of asthma among medical institutions and physician specialties in Taiwan between 2000 and 2010.

Chou CL, Perng DW, Lin TL, Lin AM, Chen TJ, Wu MS, Chou YC.

Clin Ther. 2015 Oct 1;37(10):2275-85. doi: 10.1016/j.clinthera.2015.07.024. Epub 2015 Aug 20.


Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma.

Evans DJ, Kew KM, Anderson DE, Boyter AC.

Cochrane Database Syst Rev. 2015 Jul 21;(7):CD011437. doi: 10.1002/14651858.CD011437.pub2. Review.


Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids.

Ahmad S, Kew KM, Normansell R.

Cochrane Database Syst Rev. 2015 Jun 19;(6):CD011306. doi: 10.1002/14651858.CD011306.pub2. Review.


Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood Asthma.

van Aalderen WM, Grigg J, Guilbert TW, Roche N, Israel E, Martin RJ, Colice G, Postma DS, Hillyer EV, Burden A, Thomas V, von Ziegenweidt J, Price D.

J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):721-31.e16. doi: 10.1016/j.jaip.2015.04.012. Epub 2015 May 29.

Supplemental Content

Loading ...
Support Center